AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage at the same time under a new coverage pathway announced Thursday by the FDA and the Centers for Medicare...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Memes from epidemiologist Katelyn Jetelina, PhD, MPH, advocacy organization Fired but Fighting, and others...
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Many patients taking glucagon-like peptide-1 (GLP-1) receptor agonists...
This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen now.
(MedPage Today) -- The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene therapy, lunsotogene parvec...
